Skip to main content
Top
Published in: International Urology and Nephrology 12/2016

Open Access 01-12-2016 | Nephrology - Original Paper

Association between functional variant of inflammatory system gene (PSMA6) and end-stage kidney disease

Authors: Monika Buraczynska, Anna Stec, Aleksandra Filipczak, Andrzej Ksiazek

Published in: International Urology and Nephrology | Issue 12/2016

Login to get access

Abstract

Background

The proteasome system is involved in several disorders. The 5′ untranslated region of PSMA6 gene contains a single nucleotide polymorphism (SNP) −8 C/G, associated with diabetes, myocardial infarction and coronary artery disease.

Methods

We examined 584 patients with end-stage kidney disease (ESKD) and 430 controls. All were genotyped for −8 C/G SNP by polymerase chain reaction and restriction analysis.

Results

We observed lower frequency of CG + GG genotypes in patients than in controls (20 vs. 42 %, p = 0.0038). The odds ratio of 0.34 (95 % CI 0.26–0.45) suggests association of CG + GG with decreased risk of ESKD. We investigated the association between PSMA6 polymorphism and LVH present in 54 % of patients. There was a significant association of CG + GG genotype with LVH, with over 75 % of CG + GG in patients with LVH. This effect was independent from other common causes of LVH—age (OR 1.12, p = 0.643) and hypertension (OR 1.72, p = 0.422).

Conclusion

We demonstrated for the first time that PSMA6 polymorphism might be a protective factor for ESKD. On the other hand, CG + GG genotypes are independently related to LVH in ESKD patients.
Literature
1.
go back to reference El Nahas M, Bello AK (2005) Chronic kidney disease: the global challenge. Lancet 365:331–340CrossRef El Nahas M, Bello AK (2005) Chronic kidney disease: the global challenge. Lancet 365:331–340CrossRef
2.
go back to reference Ortiz A, Covic A, Fliser D, Fouque D, Goldsmith D, Kanbay M et al (2014) Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure. Lancet 383:1831–1843CrossRefPubMed Ortiz A, Covic A, Fliser D, Fouque D, Goldsmith D, Kanbay M et al (2014) Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure. Lancet 383:1831–1843CrossRefPubMed
3.
go back to reference Böger CA, Heid IM (2011) Chronic kidney disease: novel insights from genome-wide association studies. Kidney Blood Press Res 34:225–234CrossRefPubMed Böger CA, Heid IM (2011) Chronic kidney disease: novel insights from genome-wide association studies. Kidney Blood Press Res 34:225–234CrossRefPubMed
4.
go back to reference Dwivedi RS, Herman JG, McCaffrey TA, Raj DS (2011) Beyond genetics: epigenetic code in chronic kidney disease. Kidney Int 79:23–32CrossRefPubMed Dwivedi RS, Herman JG, McCaffrey TA, Raj DS (2011) Beyond genetics: epigenetic code in chronic kidney disease. Kidney Int 79:23–32CrossRefPubMed
5.
go back to reference Naujokat C, Hoffmann S (2002) Role and function of the 26S proteasome in proliferation and apoptosis. Lab Invest 82:965–980CrossRefPubMed Naujokat C, Hoffmann S (2002) Role and function of the 26S proteasome in proliferation and apoptosis. Lab Invest 82:965–980CrossRefPubMed
6.
go back to reference Auld KL, Silver PA (2006) Transcriptional regulation by the proteasome as a mechanism for cellular protein homeostasis. Cell Cycle 5:1503–1505CrossRefPubMed Auld KL, Silver PA (2006) Transcriptional regulation by the proteasome as a mechanism for cellular protein homeostasis. Cell Cycle 5:1503–1505CrossRefPubMed
7.
go back to reference Herrmann J, Ciechanover A, Lerman LO, Lerman A (2004) The ubiquitin–proteasome system in cardiovascular diseases—a hypothesis extended. Cardiovasc Res 61:11–21CrossRefPubMed Herrmann J, Ciechanover A, Lerman LO, Lerman A (2004) The ubiquitin–proteasome system in cardiovascular diseases—a hypothesis extended. Cardiovasc Res 61:11–21CrossRefPubMed
8.
go back to reference Wang J, Maldonado MA (2006) The ubiquitin–proteasome system and its role in inflammatory and autoimmune diseases. Cell Mol Immunol 3:255–261PubMed Wang J, Maldonado MA (2006) The ubiquitin–proteasome system and its role in inflammatory and autoimmune diseases. Cell Mol Immunol 3:255–261PubMed
10.
go back to reference Sjakste T, Paramonova N, Osina K, Dokane K, Sokolovska J, Sjakste N (2016) Genetic variations in the PSMA3, PSMA6 and PSMC6 genes are associated with type 1 diabetes in Latvians and with expression level of number of UPS-related and T1DM-susceptible genes in HapMap individuals. Mol Genet Genom 291:891–903CrossRef Sjakste T, Paramonova N, Osina K, Dokane K, Sokolovska J, Sjakste N (2016) Genetic variations in the PSMA3, PSMA6 and PSMC6 genes are associated with type 1 diabetes in Latvians and with expression level of number of UPS-related and T1DM-susceptible genes in HapMap individuals. Mol Genet Genom 291:891–903CrossRef
11.
go back to reference Sjakste T, Sjakste N, Scherrer K (2001) Exon/intron organization of human proteasome PROS-27K gene. DNA Seq 12:261–265CrossRefPubMed Sjakste T, Sjakste N, Scherrer K (2001) Exon/intron organization of human proteasome PROS-27K gene. DNA Seq 12:261–265CrossRefPubMed
12.
go back to reference Schmidt M, Finley D (2013) Regulation of proteasome activity in health and disease. Biochim Biophys Acta 1843:13–25CrossRefPubMed Schmidt M, Finley D (2013) Regulation of proteasome activity in health and disease. Biochim Biophys Acta 1843:13–25CrossRefPubMed
13.
go back to reference Ozaki K, Sato H, Iida A, Mizuno H, Nakamura T, Miyamoto Y et al (2006) A functional SNP in PSMA6 confers risk of myocardial infarction in the Japanese population. Nat Genet 38:921–925CrossRefPubMed Ozaki K, Sato H, Iida A, Mizuno H, Nakamura T, Miyamoto Y et al (2006) A functional SNP in PSMA6 confers risk of myocardial infarction in the Japanese population. Nat Genet 38:921–925CrossRefPubMed
14.
go back to reference Karin M, Delhase M (2000) The IκB kinase (IKK) and NF-κB: key elements of proinflammatory signaling. Semin Immunol 12:85–98CrossRefPubMed Karin M, Delhase M (2000) The IκB kinase (IKK) and NF-κB: key elements of proinflammatory signaling. Semin Immunol 12:85–98CrossRefPubMed
15.
go back to reference Takashima N, Shioji K, Kokubo Y et al (2007) Validation of the association between the gene encoding proteasome subunit alpha type 6 and myocardial infarction in a Japanese population. Circ J 71:495–498CrossRefPubMed Takashima N, Shioji K, Kokubo Y et al (2007) Validation of the association between the gene encoding proteasome subunit alpha type 6 and myocardial infarction in a Japanese population. Circ J 71:495–498CrossRefPubMed
16.
go back to reference Barbieri M, Marfella R, Rizzo MR, Boccardi V, Siniscalchi M, Sciattarella C et al (2008) The −8 UTR C/G polymorphism of PSMA6 gene is associated with susceptibility to myocardial infarction in type 2 diabetic patients. Atherosclerosis 201:117–123CrossRefPubMed Barbieri M, Marfella R, Rizzo MR, Boccardi V, Siniscalchi M, Sciattarella C et al (2008) The −8 UTR C/G polymorphism of PSMA6 gene is associated with susceptibility to myocardial infarction in type 2 diabetic patients. Atherosclerosis 201:117–123CrossRefPubMed
17.
go back to reference Liu X, Wang X, Shen Y, Wu L, Ruan X, Lindpaintner K et al (2009) The functional variant rs1048990 in PSMA6 is associated with susceptibility to myocardial infarction in a Chinese population. Atherosclerosis 206:199–203CrossRefPubMed Liu X, Wang X, Shen Y, Wu L, Ruan X, Lindpaintner K et al (2009) The functional variant rs1048990 in PSMA6 is associated with susceptibility to myocardial infarction in a Chinese population. Atherosclerosis 206:199–203CrossRefPubMed
18.
go back to reference Wang H, Jiang H, Zhu H, Chen Q, Gong P, Lin J et al (2013) Quantitative assessment of the influence of PSMA6 variant (rs1048990) on coronary artery risk. Mol Biol Rep 40:1035–1041CrossRefPubMed Wang H, Jiang H, Zhu H, Chen Q, Gong P, Lin J et al (2013) Quantitative assessment of the influence of PSMA6 variant (rs1048990) on coronary artery risk. Mol Biol Rep 40:1035–1041CrossRefPubMed
19.
go back to reference Misra S, Kumar P, Kumar A, Sagar R, Chakravarty K, Prasad K (2016) Genetic association between inflammatory genes (IL-1α, CD14, LGALS2, PSMA6) and risk of ischemic stroke: a meta-analysis. Meta Gene 8:21–29CrossRefPubMedPubMedCentral Misra S, Kumar P, Kumar A, Sagar R, Chakravarty K, Prasad K (2016) Genetic association between inflammatory genes (IL-1α, CD14, LGALS2, PSMA6) and risk of ischemic stroke: a meta-analysis. Meta Gene 8:21–29CrossRefPubMedPubMedCentral
20.
go back to reference Freilinger T, Bevan S, Ripke S, Gschwendtner A, Lichtner P, Müller-Myhsok B et al (2009) Genetic variation in the lymphotoxin-alpha pathway and the risk of ischemic stroke in European population. Stroke 40:970–972CrossRefPubMed Freilinger T, Bevan S, Ripke S, Gschwendtner A, Lichtner P, Müller-Myhsok B et al (2009) Genetic variation in the lymphotoxin-alpha pathway and the risk of ischemic stroke in European population. Stroke 40:970–972CrossRefPubMed
21.
go back to reference Bachmann HS, Novotny J, Sixt S, Liebisch P, Frey UH, Dührsen U et al (2010) The G-allele of the PSMA6 −8C > G polymorphism is associated with poor outcome in multiple myeloma independently of circulating proteasome serum levels. Eur J Haematol 85:108–113PubMed Bachmann HS, Novotny J, Sixt S, Liebisch P, Frey UH, Dührsen U et al (2010) The G-allele of the PSMA6 −8C > G polymorphism is associated with poor outcome in multiple myeloma independently of circulating proteasome serum levels. Eur J Haematol 85:108–113PubMed
22.
go back to reference Mearini G, Schlossarek S, Willis MS, Carrier L (2008) Ubiquitin–proteasome system in cardiac dysfunction. Biochim Biophys Acta 1782:749–763CrossRefPubMed Mearini G, Schlossarek S, Willis MS, Carrier L (2008) Ubiquitin–proteasome system in cardiac dysfunction. Biochim Biophys Acta 1782:749–763CrossRefPubMed
23.
go back to reference Heckman MG, Soto-Ortolaza AI, Diehl NN, Rayaprolu S, Brott TG, Wszolek ZK et al (2013) Genetic variants associated with myocardial infarction in the PSMA6 gene and Chr 9p21 are also associated with ischemic stroke. Eur J Neurol 20:300–308CrossRefPubMed Heckman MG, Soto-Ortolaza AI, Diehl NN, Rayaprolu S, Brott TG, Wszolek ZK et al (2013) Genetic variants associated with myocardial infarction in the PSMA6 gene and Chr 9p21 are also associated with ischemic stroke. Eur J Neurol 20:300–308CrossRefPubMed
24.
go back to reference Amann K, Rychlik I, Miltenberger-Milteny G, Ritz E (1998) Left ventricular hypertrophy in renal failure. Kidney Int 54(Suppl 68):S78–S85CrossRef Amann K, Rychlik I, Miltenberger-Milteny G, Ritz E (1998) Left ventricular hypertrophy in renal failure. Kidney Int 54(Suppl 68):S78–S85CrossRef
25.
go back to reference Testa A, Mallamaci F, Benedett F, Pisano A, Tripepi G, Malatino L et al (2010) Vitamin D receptor (VDR) gene polymorphism is associated with left ventricular (LV) mass and predicts left ventricular hypertrophy (LVH) progression in end-stage renal disease (ESRD) patients. J Bone Miner Res 25:313–319CrossRefPubMed Testa A, Mallamaci F, Benedett F, Pisano A, Tripepi G, Malatino L et al (2010) Vitamin D receptor (VDR) gene polymorphism is associated with left ventricular (LV) mass and predicts left ventricular hypertrophy (LVH) progression in end-stage renal disease (ESRD) patients. J Bone Miner Res 25:313–319CrossRefPubMed
26.
go back to reference El-Shehaby AM, El-Khatib MM, Marzouk S, Battah AA (2013) Relationship of Bsm I polymorphism of vitamin D receptor gene with left ventricular hypertrophy and atherosclerosis in hemodialysis patients. Scand J Clin Lab Invest 73:75–81CrossRefPubMed El-Shehaby AM, El-Khatib MM, Marzouk S, Battah AA (2013) Relationship of Bsm I polymorphism of vitamin D receptor gene with left ventricular hypertrophy and atherosclerosis in hemodialysis patients. Scand J Clin Lab Invest 73:75–81CrossRefPubMed
27.
go back to reference Fedor R, Asztalos L, Löcsey L, Szabo L, Manyine IS, Fagyas M et al (2011) Insertion/deletion polymorphism of the angiotensin-converting enzyme predicts left ventricular hypertrophy after renal transplantation. Transplant Proc 43:1259–1260CrossRefPubMed Fedor R, Asztalos L, Löcsey L, Szabo L, Manyine IS, Fagyas M et al (2011) Insertion/deletion polymorphism of the angiotensin-converting enzyme predicts left ventricular hypertrophy after renal transplantation. Transplant Proc 43:1259–1260CrossRefPubMed
28.
go back to reference Rodrigues SL, Angelo LC, Pereira AC, Krieger JE, Mill JG (2009) Determinants of left ventricular mass and presence of metabolic risk factors in normotensive individuals. Int J Cardiol 135:323–330CrossRefPubMed Rodrigues SL, Angelo LC, Pereira AC, Krieger JE, Mill JG (2009) Determinants of left ventricular mass and presence of metabolic risk factors in normotensive individuals. Int J Cardiol 135:323–330CrossRefPubMed
Metadata
Title
Association between functional variant of inflammatory system gene (PSMA6) and end-stage kidney disease
Authors
Monika Buraczynska
Anna Stec
Aleksandra Filipczak
Andrzej Ksiazek
Publication date
01-12-2016
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 12/2016
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-016-1420-y

Other articles of this Issue 12/2016

International Urology and Nephrology 12/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.